Connect with us

Hi, what are you looking for?

News

Hedge Funds Endure Large Losses on Biotech Rout

Hedge Funds Endure Large Losses on Biotech Rout

Biotech shares have fallen to earth with a thud in 2021 after hovering final 12 months amid pleasure over the event of Covid-19 vaccines, dealing huge losses to some hedge funds.

The sector is being buffeted by considerations Congress will transfer to place a lid on drug pricing and a surfeit of early-stage biotech shares because the IPO market booms.

You May Also Like

World

France, which has opened its borders to Canadian tourists, is eager to see Canada reopen to the French. The Canadian border remains closed...

Health

Kashechewan First Nation in northern Ontario is experiencing a “deepening state of emergency” as a result of surging COVID-19 cases in the community...

World

The virus that causes COVID-19 could have started spreading in China as early as October 2019, two months before the first case was identified in the central city of Wuhan, a new study...

World

April Ross and Alix Klineman won the first Olympic gold medal for the United States in women’s beach volleyball since 2012 on Friday,...